Introduction
Gastrointestinal Drugs Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Due to changing lifestyles, increasing geriatric population, Gastrointestinal Drugs Market is on a rise. Additionally, increasing prevalence of gastrointestinal diseases and rising investment in R&D, approval of new drugs, are also major driving factors for the Gastrointestinal Drugs Market.
On the other hand, high raw material costs, increasing presence of counterfeit drugs, are some of the restraining factor for this Market.
Geographical Overview
At a global level, the North America region was holding the highest market share in 2019, due to reimbursement policies, increasing geriatric population. Europe is holding second position after North America. Whereas, Asia Pacific region is considered the fastest-growing region with key players adopting expansion strategy in this region to gain maximum market share in the coming years. Key factors such as improving healthcare infrastructure, increasing investment in R&D, are driving Gastrointestinal Drugs Market in the Asia Pacific region.
?
Segmental Overview
Gastrointestinal Drugs Market is segmented as per below specifications -
By Drug Class:
• Acid Neutralizers
o Antacids
o H2 Antagonists
o Proton Pump Inhibitors
• Antidiarrheal and Laxatives
• Antiemetic and Antinauseants
• Anti-inflammatory Drugs
• Biologics
• Antispasmodic
By Route of Administration:
• Oral
• Parenteral
• Rectal
By Disorder Type:
• Gastro-esophageal Reflux Disease
• Inflammatory Bowel Disease
• Irritable Bowel Syndrome
By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Competitor Analysis
Gastrointestinal Drugs Market has presence of some of the key major players across globe which includes
• Bayer AG
• Takeda Pharmaceuticals
• Allergen PLC
• Novo Nordisk A/S
• AstraZeneca PLC
• AbbVie Inc.
• Johnson & Johnson
• Valeant Pharmaceuticals
• GlaxoSmithKline PLC
• Sanofi
• Janssen Biotech Inc.
These key players are concentrating its efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share, companies are adopting merger/ acquisition/ partnership and maintaining strong distribution networks strategies.
By Geographical Locations:
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Italy
o Germany
o Spain
o Russia & CIS
o Rest of Europe
• Asia-Pacific
o China
o India
o Japan
o South Korea
o ASEAN
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of LATAM
• Middle East & Africa
o UAE
o South Africa
o Rest of MEA
Highlights of the report
What is Gastrointestinal Drugs Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation
Market size projection based on Historical & current market trends
Market share analysis and key strategies adopted by leading players
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations
Chapter 1 Research Objective
1.1 Need of the Research Report
1.2 Client Objectives
1.3 Offered Solutions
Chapter 2 Recommendations
2.1 Executive Summary
2.1.1 Market Overview
2.1.2 Competitive Insights
2.1.3 Segmental Analysis
2.1.4 Geographical Market Details
2.2 Lead Generation
2.3 Consultant
2.4 Return on Investment
Chapter 3 Research Methodology
3.1 Chromatus Database
3.2 Paid Sources
3.3 Primary Data Collection
3.3.1 Email Surveys
3.3.2 Telephonic Interviews
3.3.3 Face to Face Interviews
3.4 Secondary Data Collection
3.4.1 Annual Reports
3.4.2 Government Publications
3.4.3 Trade Data
3.4.4 Association Data
3.4.5 Research Papers/ Blogs/ News Articles
3.5 Expert Advisory Panel
3.6 Data Analytics Model
Chapter 4 Gastrointestinal Drugs Market Overview
4.1 Parent Market Overview
4.2 Patent Analysis
4.3 PESTEL Analysis
4.3.1 Political
4.3.2 Economical
4.3.3 Social
4.3.4 Technological
4.3.5 Legal
4.4 SWOT Analysis
4.4.1 Strengths
4.4.2 Weakness
4.4.3 Opportunities
4.4.4 Threats
4.5 Regulations
4.6 Value Chain/ Supply Chain Analysis
4.7 Procurement & Vendor Analysis
4.8 Porters Five Analysis
4.8.1 Threat of new entrants
4.8.2 Bargaining power of suppliers
4.8.3 Bargaining power of buyers
4.8.4 Threat of substitutes
4.8.5 Competitive rivalry
Chapter 5 Regional Analysis
Global Gastrointestinal Drugs Market Estimation and Forecast, 2019 - 2025 (USD Billion)
5.1 North America Market
5.1.1 U.S.
5.1.1 Canada
5.2 Europe Market
5.2.1 UK
5.2.2 Germany
5.2.3 France
5.2.4 Spain
5.2.5 Italy
5.2.6 Russia & CIS
5.2.7 Rest of Europe
5.3 Asia Pacific Market
5.3.1 China
5.3.2 Japan
5.3.3 India
5.3.4 South Korea
5.3.5 ASEAN
5.3.6 Rest of Asia Pacific
5.4 Rest of the World
5.4.1 Latin America
5.4.1.1 Brazil
5.4.1.2 Argentina
5.4.1.3 Rest of Latin America
5.4.2 Middle East
5.4.3 Africa
Chapter 6 Company Profile
6.1 Bayer AG
6.1.1 Introduction
6.1.2 Financial Overview
6.1.3 Product Portfolio
6.1.4 Recent Developments
6.1.5 SWOT Analysis
6.2 Takeda Pharmaceuticals
6.3 Allergen PLC
6.4 Novo Nordisk A/S
6.5 AstraZeneca PLC
6.6 AbbVie Inc.
6.7 Johnson & Johnson
6.8 Valeant Pharmaceuticals
6.9 GlaxoSmithKline PLC
6.10 Sanofi
6.11 Janssen Biotech Inc.
Chapter 7 Competitor Analysis
7.1 Company Ranking
7.2 Key Innovators
7.3 Market Leader
7.4 Emerging Players
7.5 Strategic Alliances
7.6 Competitive Matrix of 11 Companies
Chapter 8 Global Gastrointestinal Drugs Market by Drug Class Estimation and Forecast, 2019 - 2025 (USD Billion)
8.1 Acid Neutralizers
8.1.1 Antacids
8.1.2 H2 Antagonists
8.1.3 Proton Pump Inhibitors
8.2 Antidiarrheal and Laxatives
8.3 Antiemetic and Antinauseants
8.4 Anti-inflammatory Drugs
8.5 Biologics
8.6 Antispasmodic
Chapter 9 Global Gastrointestinal Drugs Market by Route of Administration Estimation and Forecast, 2019 - 2025 (USD Billion)
9.1 Oral
9.2 Parenteral
9.3 Rectal
Chapter 10 Global Gastrointestinal Drugs Market by Disorder Type Estimation and Forecast, 2019 - 2025 (USD Billion)
10.1 Gastro-esophageal Reflux Disease
10.2 Inflammatory Bowel Disease
10.3 Irritable Bowel Syndrome
Chapter 11 Global Gastrointestinal Drugs Market by Distribution Channel Estimation and Forecast, 2019 - 2025 (USD Billion)
11.1 Hospital Pharmacies
11.2 Retail Pharmacies
11.3 Online Pharmacies
Chapter 12 Appendix
12.1 Data Sources
12.2 Abbreviations
12.3 About US
12.4 Disclaimer
12.5 Key Notes
List of Tables
Table 1 Global Gastrointestinal Drugs Market, by Region, 2019 - 2025 (USD Billion)
Table 2 Global Gastrointestinal Drugs Market, by Drug Class, 2019 - 2025 (USD Billion)
Table 3 Global Gastrointestinal Drugs Market, by Route of Administration, 2019 - 2025 (USD Billion)
Table 4 Global Gastrointestinal Drugs Market, by Distribution Type, 2019 - 2025 (USD Billion)
Table 5 North America Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 6 North America Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 7 North America Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 8 North America Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 9 US Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 10 Canada Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 11 Europe Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 12 Europe Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 13 Europe Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 14 Europe Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 15 UK Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 16 Germany Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 17 France Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 18 Spain Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 19 Italy Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 20 Russia & CIS Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 21 Rest of Europe Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 22 Asia Pacific Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 23 Asia Pacific Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 24 Asia Pacific Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 25 Asia Pacific Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 26 China Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 27 Japan Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 28 India Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 29 South Korea Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 30 ASEAN Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 31 Rest of Asia Pacific Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 32 Latin America Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 33 Latin America Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 34 Latin America Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 35 Latin America Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 36 Brazil Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 37 Argentina Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 38 Rest of Latin America Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 39 Middle East Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 40 Middle East Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 41 Middle East Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 42 Middle East Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
Table 43 Africa Gastrointestinal Drugs Market 2019 - 2025 (USD Billion)
Table 44 Africa Gastrointestinal Drugs Market by Drug Class 2019 - 2025 (USD Billion)
Table 45 Africa Gastrointestinal Drugs Market by Route of Administration 2019 - 2025 (USD Billion)
Table 46 Africa Gastrointestinal Drugs Market by Distribution Type 2019 - 2025 (USD Billion)
?
List of Figures
Fig. 1 Primary Research Method
Fig. 2 Secondary Research Method
Fig. 3 Value chain analysis
Fig. 4 PESTEL Analysis
Fig. 5 SWOT Analysis
Fig. 6 Porters Five forces analysis
Fig. 7 Gastrointestinal Drugs Market: Penetration & growth prospect mapping
Fig. 8 Gastrointestinal Drugs Market: Competitive snapshot
Fig. 9 Gastrointestinal Drugs Market: Segmental snapshot
Fig. 10 Market Overview
Fig. 11 Gastrointestinal Drugs Market: Product Analysis, 2019 - 2025
Fig. 12 Gastrointestinal Drugs Market: Regional Analysis, 2019 - 2025
Fig. 13 Gastrointestinal Drugs Market: Competitive Matrix
Fig. 14 Gastrointestinal Drugs Market: Revenue Mix